comparemela.com

Latest Breaking News On - Zydus life - Page 1 : comparemela.com

Traders, Media Seek FOIA Docs about India Pharma

Traders, Media Seek FOIA Docs about India Pharma
lawstreetmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lawstreetmedia.com Daily Mail and Mail on Sunday newspapers.

United statesWhite houseDistrict of columbiaGeorgetown universityBruxelles capitaleLibrela bedinvetmabLonza biologicsMary denigan macauleyHogan lovellsParawada mandalCathy mcmorris rodgersr washSun pharma dadraZydus lifescienceSkyclarys omaveloxoloneSarah mcmullenEugia steriles

Sharekhan By BNP Paribas: 2 top stock picks from Foram Parekh for near term

Sharekhan By BNP Paribas: 2 top stock picks from Foram Parekh for near term
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshUnited statesUttar pradeshZydus lifesciencesForam parekhOffering collegeIndian school of businessNorth americaZydus lifeLeadership excellencePithampur unit

Hot Stocks: Brokerage view on Phoenix Mills, Anupam Rasayan; CLSA downgrades Delhivery

CLSA downgraded Delhivery to underperform, Jefferies raised Zydus Life target, and Anupam Rasayan had balance sheet concerns. Citigroup recommended buying Phonix Mills.

Anupam rasayanZydus lifePhoenix mills

sanjiv bhasin stock recommendations: Sanjiv Bhasin is bullish on these 7 stocks, recommends avoiding Zee

Sanjiv Bhasin suggests holding RattanIndia for further gains. His top picks include Embassy Office and Wipro, with potential gains to Rs 450 and Rs 700, respectively. Zydus and Lupin stand out in pharma, while Zee remains an avoid due to management issues.

Uttar pradeshSanjiv bhasinEmbassy officeOffering collegeIndian school of businessLeadership excellenceEngineers indiaZydus life

Zydus Life Q4 results: Net profit sees four-fold jump at Rs 1,182 crore

Zydus Life Q4: Revenue came in at Rs 5,533 crore,10 percent higher from the year-ago quarter

Bombay stock exchangeZydus lifeCadila laboratories

vimarsana © 2020. All Rights Reserved.